Cutaneous adverse events following treatment with third-generation EGFR tyrosine kinase inhibitors

MeSH terms

• Acrylamides / adverse effects
• Acrylamides / therapeutic use
• Aged
• Aniline Compounds / adverse effects
• Aniline Compounds / therapeutic use
• Antineoplastic Agents / adverse effects
• Antineoplastic Agents / therapeutic use
• Drug Eruptions / etiology
• ErbB Receptors* / antagonists & inhibitors
• Erlotinib Hydrochloride / adverse effects
• Erlotinib Hydrochloride / therapeutic use
• Female
• Humans
• Indoles*
• Male
• Middle Aged
• Protein Kinase Inhibitors* / adverse effects
• Protein Kinase Inhibitors* / therapeutic use
• Pyrimidines*
• Tyrosine Kinase Inhibitors